PNV OB DHA- vitamin c, calcium, iron, vitamin d3, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium, docosahexaenoic acid (dha) 
PureTek Corporation

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

Prescribing Information

DESCRIPTION:

PharmaPure Rx PNV OB + DHA is a prescription prenatal/postnatal multivitamin/mineral caplet and a softgel of an essential fatty acid. The prenatal vitamin is a light purple, capsule-shaped multivitamin/mineral caplet. The caplet is imprinted with the code "P-116" on one side and is blank on the other side. The essential fatty acid DHA softgel is clear and contains a pale yellow semi-solid mixture.

Each PNV OB+DHA caplet contains:

Vitamin C (Ascorbic acid) 120 mg
Calcium (Calcium citrate)125 mg
Iron (Carbonyl iron, Ferrous gluconate)27 mg
Vitamin D3 (Cholecalciferol)400 IU
Vitamin E (dl-alpha tocopheryl acetate)30 IU
Vitamin B1 (Thiamine HCl)3 mg
Vitamin B2 (Riboflavin)3.4 mg
Vitamin B3 (Niacinamide)20 mg
Vitamin B6 (Pyridoxine HCl)20 mg
Folic Acid1 mg
Iodine (Potassium iodide)150 mcg
Zinc (Zinc oxide)25 mg
Copper (Cupric oxide)2 mg
Docusate Sodium 50 mg

Other ingredients in DHA caplet: Croscarmellose Sodium, Crospovidone, FD and C Blue #2 Aluminum Lake, Gelatin, Hydrogenated Soybean Oil, Hypromellose, Magnesium Stearate, Microcrystalline Cellulose, Polydextrose, Polyethylene Glycol, Polysorbate 80, Povidone, Red Iron Oxide, Silicon Dioxide, Starch, Stearic Acid, Sucrose, Titanium Dioxide, Triacetin.


Each PNV OB+DHA softgel contains:

250 mg Docosahexaenoic Acid (DHA)

Supplement Facts
Serving Size: 1 Softgel   %Daily Value
Docosahexaenoic Acid (DHA)       250 mg*
*Daily Value not established.


DHA is contained in the oil derived from fish (tuna). Other ingredients in DHA softgel:Gelatin, Water, Glycerin, Polysorbate 80.
May contain Vanillin.

Also contains Eicosapentaenoic Acid (EPA) and other omega-3 fatty acids.

Cloudiness of the softgel is a characteristic of natural fish oil.

Contains Soy.

Docusate sodium is a gentle and effective stool softener that protects against the discomfort of constipation.

Contains NO artificial flavors or preservatives, yeast, wheat, gluten, nuts or milk-based by-products.


PNV OB+DHA supplies important prenatal vitamins, minerals and nutrients to supplement the nutritional needs of women, before, during and after pregnancy. Deficiencies of these nutrients are common during pregnancy and lactation and should be prescribed by a physician prior to conception.

PNV OB+DHA caplet is manufactured in a drug registered cGMP (current good manufacturing practice) facility and meets or exceeds USP standards for potency, purity and dissolution. PNV OB+DHA softgel complies with the most stringent worldwide standards for fish oil and is manufactured in a NSF-Certified cGMP Facility.

INDICATIONS AND USAGE:

PNV OB+DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

DOSAGE AND ADMINISTRATION:

Before, during and after pregnancy, one caplet and one softgel taken by mouth daily, or as prescribed by a physician. The caplet and softgel may be taken together or at different times of the day.

CONTRAINDICATIONS:

PNV OB+DHA is contraindicated in patients with a known hypersensitivity  to any of the ingredients.

WARNING:

Accidental overdose of Iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or Poison Control Center immediately.

Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including increased bleeding time and reduced clotting ratio (INR). Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis. Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.

PRECAUTIONS:

Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

Exercise caution to ensure that the prescribed dosage of DHA doses not exceed 1 gram (1,000 mg) per day.

NOTICE: Contact with moisture can discolor or erode the caplet.

ADVERSE REACTIONS:

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

Caution should be exercised with patients with known allergies to fish or fish by-products.

Call your doctor for medical advice about side effects. You may report suspected side effects to the FDA at 1-800-FDA-1088.

USE IN SPECIFIC POPULATIONS:

PNV OB+DHA is not indicated for pediatric or geriatric use.

HOW SUPPLIED:

PNV OB+DHA (NDC 59088-115-60) is a 30-day regimen supplied as six child-resistant blister cards each containing 5 light purple PNV OB+DHA prenatal capsule-shaped caplets NDC:59088-116-54 imprinted "P-116" and 5 pale yellow DHA softgels NDC: 59088-117-54 each.

Store at temperature 20°-25°C (68°-77°F).[See USP Controlled Room Temperature]. Keep in a cool, dry place.




Carton

image of carton

PNV OB DHA 
vitamin c, calcium, iron, vitamin d3, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium, docosahexaenoic acid (dha) kit
Product Information
Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:59088-115
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:59088-115-606 in 1 CARTON06/01/201105/29/2019
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
Quantity of Parts
Part #Package QuantityTotal Product Quantity
Part 1
Part 2
Part 1 of 2
PRENATAL VITAMIN 
vitamin c, calcium, iron, vitamin d3, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, folic acid, iodine, zinc, copper, docusate sodium tablet
Product Information
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ASCORBIC ACID (UNII: PQ6CK8PD0R) (ASCORBIC ACID - UNII:PQ6CK8PD0R) ASCORBIC ACID120 mg
CALCIUM CITRATE (UNII: MLM29U2X85) (CALCIUM CATION - UNII:2M83C4R6ZB) CALCIUM CITRATE ANHYDROUS125 mg
FERROUS GLUCONATE (UNII: U1B11I423Z) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION0.1 mg
IRON PENTACARBONYL (UNII: 6WQ62TAQ6Z) (FERROUS CATION - UNII:GW89581OWR) FERROUS CATION26.9 mg
CHOLECALCIFEROL (UNII: 1C6V77QF41) (CHOLECALCIFEROL - UNII:1C6V77QF41) CHOLECALCIFEROL400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8) (.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) .ALPHA.-TOCOPHEROL, DL-30 [iU]
THIAMINE HYDROCHLORIDE (UNII: M572600E5P) (THIAMINE ION - UNII:4ABT0J945J) THIAMINE HYDROCHLORIDE3 mg
RIBOFLAVIN (UNII: TLM2976OFR) (RIBOFLAVIN - UNII:TLM2976OFR) RIBOFLAVIN3.4 mg
NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4) NIACINAMIDE20 mg
PYRIDOXINE HYDROCHLORIDE (UNII: 68Y4CF58BV) (PYRIDOXINE - UNII:KV2JZ1BI6Z) PYRIDOXINE HYDROCHLORIDE20 mg
FOLIC ACID (UNII: 935E97BOY8) (FOLIC ACID - UNII:935E97BOY8) FOLIC ACID1 mg
POTASSIUM IODIDE (UNII: 1C4QK22F9J) (IODIDE ION - UNII:09G4I6V86Q) IODIDE ION150 ug
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC CATION - UNII:13S1S8SF37) ZINC CATION25 mg
CUPRIC OXIDE (UNII: V1XJQ704R4) (CUPRIC CATION - UNII:8CBV67279L) CUPRIC CATION2 mg
DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
Inactive Ingredients
Ingredient NameStrength
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
CROSPOVIDONE (UNII: 2S7830E561)  
FD&C BLUE NO. 2 (UNII: L06K8R7DQK)  
GELATIN (UNII: 2G86QN327L)  
HYDROGENATED SOYBEAN OIL (UNII: A2M91M918C)  
HYPROMELLOSE 2910 (15 MPA.S) (UNII: 36SFW2JZ0W)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
POLYDEXTROSE (UNII: VH2XOU12IE)  
POLYETHYLENE GLYCOL 8000 (UNII: Q662QK8M3B)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STARCH, CORN (UNII: O8232NY3SJ)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
SUCROSE (UNII: C151H8M554)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TRIACETIN (UNII: XHX3C3X673)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
Product Characteristics
Colorpurple (Light purple) Scoreno score
ShapeCAPSULE (capsule-shaped caplets) Size21mm
FlavorImprint Code P116
Contains    
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other
Part 2 of 2
DHA 
docosahexaenoic acid capsule, gelatin coated
Product Information
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
DOCONEXENT (UNII: ZAD9OKH9JC) (DOCONEXENT - UNII:ZAD9OKH9JC) DOCONEXENT250 mg
Inactive Ingredients
Ingredient NameStrength
GELATIN (UNII: 2G86QN327L)  
WATER (UNII: 059QF0KO0R)  
GLYCERIN (UNII: PDC6A3C0OX)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
Product Characteristics
Coloryellow (pale yellow) Scoreno score
ShapeCAPSULE (Softgel) Size21mm
FlavorImprint Code NONE
Contains    
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other06/01/201105/29/2019
Labeler - PureTek Corporation (785961046)
Establishment
NameAddressID/FEIBusiness Operations
PureTek Corporation785961046manufacture(59088-115)

Revised: 5/2019
 
PureTek Corporation